Atara Biotherapeutics Priced, Nasdaq: ATRA

Early-stage biotech targeting muscle loss in patients with end-stage renal disease.

Industry: Health Care

Latest Trade: $19.05 0.00 (0.0%)

First Day Return: -3.2%

Return from IPO: +73.2%

Industry: Health Care

Early-stage biotech targeting muscle loss in patients with end-stage renal disease.
more less
IPO News for Atara Biotherapeutics
more
IPO Data
IPO File Date 06/20/2014
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.0
Deal Size ($mm) $55
IPO Data
IPO Date 10/15/2014
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.0
Deal Size ($mm) $55
Underwriters
more
Company Data
Headquarters Brisbane, CA
Founded 2012
Employees 15
Website www.atarabio.com